CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Clinical trials for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to fix chemo side effect that leaves cancer survivors at risk of bleeding
Disease control Recruiting nowThis study tests whether adding a vitamin A-like drug (ATRA) to a platelet-boosting medication (romiplostim N01) works better than the platelet drug alone for cancer survivors whose platelet counts stay low after chemotherapy. About 220 adults with gynecologic, breast, or lung ca…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New combo aims to fix chemo side effect in GI cancer survivors
Disease control Recruiting nowThis study looks at adults whose platelet counts stayed low after finishing chemotherapy for gastrointestinal cancers (like stomach, pancreas, or colorectal). Participants get either a standard platelet-boosting drug alone or combined with another medicine (ATRA) for 12 weeks. Th…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Can a platelet-boosting drug keep chemo on track for kids with ewing sarcoma?
Symptom relief Recruiting nowThis early-phase trial tests whether romiplostim, a drug that helps the body make more platelets, can prevent dangerously low platelet counts caused by chemotherapy in children with newly diagnosed Ewing sarcoma. About 26 participants will receive romiplostim alongside their stan…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated May 17, 2026 00:27 UTC
-
New hope for young cancer patients: drug may fix Chemo-Induced low platelets
Symptom relief Recruiting nowThis study tests a drug called romiplostim N01 in children and young adults (ages 6-24) with cancer who have low platelets from chemotherapy. The goal is to see if weekly injections can safely raise platelet counts and reduce bleeding risk. About 50 participants will receive the …
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC
-
Home blood tests could spare cancer patients unnecessary hospital trips
Knowledge-focused Recruiting nowThis study explores whether cancer patients undergoing chemotherapy can monitor their own blood counts at home instead of traveling to the hospital for every test. About 265 adults with cancer from Denmark, Poland, and Germany will participate, with some using home monitoring and…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Sponsor: Pomeranian Medical University Szczecin • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC